U.S. Glaucoma Pharmaceuticals Market

 


This research service explores the market for prescription ophthalmics used for the treatment of glaucoma in the United States of America. It analyzes the various challenges faced by pharmaceutical and biotech companies, and the competitive advantages and disadvantages of their products in the market.
USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

Table of Contents

U.S. Glaucoma Pharmaceuticals Market, Executive SummaryExecutive SummaryOverviewU.S. Glaucoma Pharmaceuticals Market, U.S. Glaucoma Pharmaceuticals MarketResearch Scope and MethodologyScope and SegmentationResearch MethodologyMarket OverviewIntroductionDisease OverviewPatient ForecastsOcular HypertensionOpen-Angle GlaucomaMarket TrendsIndustry Challenges and StrategiesMarket DriversU.S. Glaucoma Pharmaceuticals Market, Product and Pipeline AnalysisApproved Therapies and Treatment OverviewTreatment OverviewProstaglandin AnaloguesBeta-BlockersCombination TherapiesCarbonic Anhydrase InhibitorsAlpha Adrenergic AgonistsPipeline AnalysisGlaucoma PipelineU.S. Glaucoma Pharmaceuticals Market, Competitive AnalysisIntroductionMarket Engineering MeasurementsPrice TrendsCompetitive StructureMarket Share and Revenue ForecastsMarket ShareRevenue ForecastU.S. Glaucoma Pharmaceuticals Market, AppendixDecision Support DatabasesTotal PopulationPopulation Aged 65 and UpGlaucoma PrevalenceGlaucoma IncidenceGlaucoma Drugs in Clinical Trials




Related Research

Release Date : 11-Aug-17

Region : North America

Release Date : 10-Aug-17

Region : North America

Release Date : 09-Aug-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.